Britain's health regulator said on Friday it had approved a maximum weekly dose of up to 7.2 milligrams of Novo Nordisk's ...

Novo Nordisk stock rose 4% after the U.K. approved a higher 7.2mg Wegovy dose and early prescription data showed strong ...

Investing.com -- The Medicines and Healthcare products Regulatory Agency approved a maximum dose of up to 7.2 milligrams per week of Novo Nordisk’s (CSE:NOVOb) weight-loss drug Wegovy for patients ...

UK MHRA approves up to 7.2mg dose of semaglutide for patients with obesity only: United Kingdom Saturday, January 17, 2026, 13:00 Hrs [IST] The UK Medicines and Healthcare product ...

Wegovy 7.2 mg has been approved for use in the UK, offering a stronger weight-loss injection as demand rises. Here is what ...

Comprehensive comparison of daily oral vs weekly injectable Wegovy following Novo Nordisk's January 2026 FDA approval of the ...

Does the new Wegovy pill work as well as Wegovy injections for weight loss? How else does it compare? Learn what the experts ...

Novo Nordisk shares jumped early Friday after UK regulators cleared a higher weekly dose of the company's Wegovy weight loss ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

NVO jumps nearly 19% in a month primarily on the FDA approval and launch of oral Wegovy, the first GLP-1 pill for obesity and ...